PerkinElmer

PerkinElmer is a global leader in the Life sciences and Diagnostics industry, providing innovative solutions to scientists, researchers, and clinicians at Harvard University, Stanford University, and Massachusetts Institute of Technology. With a rich history spanning over 80 years, the company has established itself as a trusted partner for Pfizer, Merck & Co., and GlaxoSmithKline. PerkinElmer's products and services are used in various fields, including Genomics, Proteomics, and Cellular Imaging, and have contributed to significant advancements in Cancer Research at National Cancer Institute and American Cancer Society. The company's commitment to innovation has earned it numerous awards, including the R&D 100 Award and the Edison Award, presented by Thomas Edison and National Science Foundation.

● History

PerkinElmer was founded in 1937 by Richard Perkin and Charles Elmer, with the goal of providing high-quality Spectroscopy instruments to researchers at University of California, Berkeley and California Institute of Technology. Over the years, the company has undergone significant transformations, including the acquisition of Applied Biosystems in 2008, which expanded its portfolio to include Genomics and Proteomics solutions used by National Institutes of Health and World Health Organization. PerkinElmer has also collaborated with renowned institutions, such as MIT and Harvard University, to develop innovative technologies, including the Spectrum Two FTIR Spectrometer, used by NASA and European Space Agency. The company's history is marked by significant milestones, including the development of the first Atomic Absorption Spectrometer in the 1960s, which revolutionized the field of Analytical Chemistry at University of Cambridge and University of Oxford.

● Products and Services

PerkinElmer offers a wide range of products and services, including Spectroscopy instruments, such as the Spectrum Two and LAMBDA series, used by Dow Chemical Company and DuPont. The company's Genomics and Proteomics solutions, including the Operetta CLS and AlphaLISA platforms, are used by researchers at University of California, Los Angeles and University of Chicago. PerkinElmer also provides Cellular Imaging solutions, such as the Operetta CLS and In Cell Analyzer, used by Bristol-Myers Squibb and AstraZeneca. The company's services include Method Development and Validation for Pharmaceutical and Biotechnology companies, such as Johnson & Johnson and Roche Holding. PerkinElmer's products and services are used in various applications, including Cancer Research at MD Anderson Cancer Center and Memorial Sloan Kettering Cancer Center, Neuroscience at University of Pennsylvania and University of California, San Francisco, and Environmental Monitoring at Environmental Protection Agency and World Wildlife Fund.

● Research and Development

PerkinElmer is committed to innovation and has a strong focus on Research and Development, with collaborations with renowned institutions, such as Stanford University and Massachusetts Institute of Technology. The company's research efforts are focused on developing new technologies and solutions for various fields, including Genomics, Proteomics, and Cellular Imaging, used by Broad Institute and Whitehead Institute. PerkinElmer has developed innovative solutions, such as the Spectrum Two FTIR Spectrometer, which has been used in various applications, including Materials Science at University of Michigan and University of Texas at Austin. The company's research and development efforts have earned it numerous awards, including the R&D 100 Award and the Edison Award, presented by National Science Foundation and American Association for the Advancement of Science.

● Acquisitions and Partnerships

PerkinElmer has made several strategic acquisitions and partnerships to expand its portfolio and capabilities, including the acquisition of Applied Biosystems in 2008, which added Genomics and Proteomics solutions to its portfolio, used by Illumina, Inc. and Thermo Fisher Scientific. The company has also partnered with renowned institutions, such as Harvard University and MIT, to develop innovative technologies, including the Spectrum Two FTIR Spectrometer, used by Los Alamos National Laboratory and Lawrence Livermore National Laboratory. PerkinElmer has also collaborated with companies, such as Pfizer and Merck & Co., to develop new solutions for various applications, including Cancer Research at National Cancer Institute and American Cancer Society. The company's partnerships have enabled it to expand its reach and provide innovative solutions to customers, including GlaxoSmithKline and AstraZeneca.

● Operations and Locations

PerkinElmer operates globally, with headquarters in Waltham, Massachusetts, and has operations in over 150 countries, including United States, China, and India. The company has a strong presence in various regions, including Europe, Asia Pacific, and Latin America, with offices in London, Tokyo, and Sao Paulo. PerkinElmer's global operations are supported by a network of Distributors and Partners, including Thermo Fisher Scientific and Agilent Technologies, which provide sales, service, and support to customers, including Dow Chemical Company and DuPont. The company's global reach and local presence enable it to provide innovative solutions to customers, including Bristol-Myers Squibb and Roche Holding, and to support various applications, including Cancer Research at MD Anderson Cancer Center and Memorial Sloan Kettering Cancer Center.